Adial Pharmaceuticals Balance Sheet (2017-2026)

Reported Financials

Adial Pharmaceuticals Quarterly Balance Sheet

Periods 37 quarters

Latest Jun 2026

Adial Pharmaceuticals reported total assets of $29.09M and total liabilities of $67.47M for the quarter ended Jun 2026, up 327.7% year over year. This balance sheet covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	7.18M	6.06M	12.69M	9.16M	5.75M	4.00M	2.31M	1.22M	0.32M	2.83M	5.03M	3.29M	5.20M	3.75M	2.37M	5.92M	4.61M	5.88M	4.58M	28.71M
Receivables - NetNet Receivables														0.06M				0.04M
Receivables														0.06M				0.04M
Prepaid Assets	0.57M	0.39M	0.27M	0.59M	0.52M	0.35M	0.43M	0.09M	0.47M	0.37M	0.28M	0.35M	0.41M	0.31M	0.26M	0.16M	0.41M	0.30M	0.22M	0.13M
Current Assets	7.99M	6.46M	12.96M	9.94M	6.77M	4.78M	2.96M	2.05M	1.14M	3.20M	5.34M	3.82M	5.62M	4.06M	2.63M	6.08M	5.01M	6.18M	4.80M	28.84M
Non-Current Assets
Property, Plant & Equipment (Net)	0.06M	0.06M	0.06M	0.05M	0.05M	0.05M	0.05M
Long-Term Investments								1.73M	1.73M	1.53M	1.34M	1.12M	1.09M	0.98M	1.73M	1.73M	1.73M	0.49M	0.42M	0.24M
Goodwill	0.13M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M
Intangibles	0.01M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Goodwill & Intangibles	0.14M	0.25M	0.25M	0.25M	0.25M	0.25M	0.25M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Other Non-Current Assets		0.25M	0.23M	0.22M		0.95M	0.43M
Non-Current Assets	2.46M	1.01M	1.00M	0.98M	0.97M	0.95M	0.94M	1.73M	3.37M	3.35M	3.83M	3.81M	3.51M	3.51M	3.47M	3.45M	0.65M	3.44M	0.42M	0.24M
Assets	10.45M	7.47M	13.96M	10.92M	7.74M	5.73M	3.90M	3.78M	2.87M	4.74M	6.68M	4.95M	6.71M	5.04M	3.45M	6.80M	5.66M	6.67M	5.23M	29.09M
Liabilities
Current Liabilities
Accounts Payables	0.19M	0.29M	0.42M	0.62M	0.28M	0.28M	0.53M	0.11M	0.08M	0.10M	0.18M	0.32M	0.32M	0.25M	0.53M	0.67M	0.56M	0.66M	0.57M	2.62M
Notes Payables
Payables	0.19M	0.29M	0.42M	0.62M	0.28M	0.28M	0.53M	0.11M	0.08M	0.10M	0.18M	0.32M	0.32M	0.25M	0.53M	0.67M	0.56M	0.66M	0.57M	2.62M
Accumulated Expenses	1.72M	2.38M	1.69M	1.01M	0.96M	0.96M	1.18M	0.32M	0.41M	0.48M	0.38M	0.34M	0.50M	0.68M	0.76M	0.54M	0.60M	0.74M	0.94M	2.50M
Other Accumulated Expenses	0.44M	0.52M	0.36M	0.50M	0.69M	0.76M	1.09M	0.28M	0.35M	0.42M	0.20M	0.27M	0.41M	0.41M	0.59M	0.37M	0.51M	0.66M	0.84M	1.46M
Short term Debt
Current Leases	0.05M	0.05M	0.05M	0.05M	0.05M	0.06M	0.06M
Total Current Liabilities	1.96M	2.72M	2.17M	1.87M	1.33M	1.79M	1.80M	0.46M	0.53M	0.65M	0.56M	0.67M	0.83M	0.98M	1.32M	1.21M	1.15M	1.40M	1.51M	5.12M
Non-Current Liabilities
Capital Leases	1.07M	1.01M	0.87M	0.89M	0.82M	0.49M	0.51M
Non-Current Debt
Convertible Debt
Preferred Stock Liabilities																				38.53M
Liabilities from Discontinued Operations						0.67M
Operating Leases		0.21M	0.19M	0.18M	0.17M	0.15M	0.14M
Non-Current Deferred Tax Liability		0.02M	0.02M	0.02M	0.02M	0.00M	0.02M
Other Non-Current Liabilities						0.67M														23.81M
Total Non-Current Liabilities						1.79M			0.52M	0.56M	0.30M	0.45M	0.93M	0.93M	1.98M	2.40M		6.91M		43.65M
Total Liabilities	3.25M	3.97M	3.26M	2.96M	2.33M	2.46M	2.46M	0.46M	0.53M	0.65M	0.56M	0.67M	0.83M	0.98M	1.33M	1.21M	1.15M	1.40M	1.51M	67.47M
Shareholder's Equity
Total Debt
Common Equity	7.20M	3.51M	10.71M	7.96M	5.41M	3.28M	1.44M	3.32M	2.34M	4.08M	6.12M	4.28M	5.88M	4.07M	2.13M	5.59M	4.51M	5.28M	3.72M	-38.38M
Liabilities and Shareholders Equity	10.45M	7.47M	13.96M	10.92M	7.74M	5.73M	3.90M	3.78M	2.87M	4.74M	6.68M	4.95M	6.71M	5.04M	3.45M	6.80M	5.66M	6.67M	5.23M	29.09M
Retained Earnings	-45.11M	-50.94M	-53.90M	-57.70M	-60.81M	-63.67M	-66.58M	-65.49M	-66.88M	-68.80M	-75.27M	-77.73M	-79.92M	-82.00M	-84.22M	-86.18M	-87.98M	-89.97M	-91.99M	-143.98M
Preferred Shares												0.08M

Adial Pharmaceuticals Balance Sheet API

Pull Adial Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ADIL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "ADIL", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=ADIL&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Adial Pharmaceuticals ADIL Balance Sheet (2017-2026)

Adial Pharmaceuticals Quarterly Balance Sheet

Adial Pharmaceuticals Balance Sheet API

Create an account

Sign In

Reset Password